Field effect of two commercial preparations of botulinum toxin type A: A prospective, double-blind, randomized clinical trial

Background The dose equivalence of commonly used commercial preparations of botulinum toxin type A, Dysport (abotulinumtoxinA [ABO] 500 U, Ipsen Biopharm Limited, Wrexham, United Kingdom) and Botox (onabotulinumtoxinA [ONA] 100 U, Allergan, Irvine, CA), remains unclear. Objective We sought to evalua...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Academy of Dermatology 2012-08, Vol.67 (2), p.226-232
Hauptverfasser:	Hexsel, Doris, MD, Brum, Cristiano, MD, do Prado, Débora Zechmeister, BPharm, Soirefmann, Mariana, MD, MSc, Rotta, Francisco Telechea, MD, Dal’Forno, Taciana, MD, PhD, Rodrigues, Ticiana C., MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Action Potentials Adolescent Adult anhidrotic action halos Biological and medical sciences botulinum toxin type A Botulinum Toxins, Type A - administration & dosage Dermatology dose equivalence Dose-Response Relationship, Drug Double-Blind Method Facial Muscles - drug effects Facial Muscles - innervation Female field effect Forehead Humans Medical sciences Middle Aged Neurotoxins - administration & dosage Prospective Studies Severity of Illness Index Skin Aging - drug effects Skin Aging - pathology Sweat Glands - drug effects Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!